2022 Help me understand this report
COVID-19 with baricitinib-induced symptomatic creatinine kinase elevation
Abstract: Creatinine kinase elevation should be suspected if a patient receiving baricitinib for COVID-19 infection complains of myalgia during treatment, and the drug should be discontinued immediately.
Search citation statements
Paper Sections
Select...
Citation Types
0
0
0
Year Published
2022
2022
Publication Types
Select...
1
Relationship
0
1
Authors
Journals
Cited by 1 publication
References 5 publications
0
0
0
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
